157 related articles for article (PubMed ID: 8721589)
1. Immunohistochemical study of primary and recurrent basal cell and metatypical carcinomas of the skin.
Kazantseva IA; Khlebnikova AN; Babaev VR
Am J Dermatopathol; 1996 Feb; 18(1):35-42. PubMed ID: 8721589
[TBL] [Abstract][Full Text] [Related]
2. [Proliferative activity of basal cell and metatypical cell carcinoma of the skin].
Kazantseva IA; Khlebnikova AN; Babaev VR; Fager G
Arkh Patol; 1994; 56(4):35-8. PubMed ID: 7848103
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical nuclear staining for p53, PCNA, and Ki-67 in different histologic variants of basal cell carcinoma.
Barrett TL; Smith KJ; Hodge JJ; Butler R; Hall FW; Skelton HG
J Am Acad Dermatol; 1997 Sep; 37(3 Pt 1):430-7. PubMed ID: 9308559
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical evaluation of basal cell carcinoma and trichepithelioma using Bcl-2, Ki67, PCNA and P53.
Abdelsayed RA; Guijarro-Rojas M; Ibrahim NA; Sangueza OP
J Cutan Pathol; 2000 Apr; 27(4):169-75. PubMed ID: 10774937
[TBL] [Abstract][Full Text] [Related]
5. The immunohistochemical characteristics of the basosquamous cell carcinoma.
Jones MS; Helm KF; Maloney ME
Dermatol Surg; 1997 Mar; 23(3):181-4. PubMed ID: 9145960
[TBL] [Abstract][Full Text] [Related]
6. Fatal outcome in a metatypical, giant, "horrifying" basal cell carcinoma.
Bianchini R; Wolter M
J Dermatol Surg Oncol; 1987 May; 13(5):556-7. PubMed ID: 3571694
[TBL] [Abstract][Full Text] [Related]
7. Ber EP4 and epithelial membrane antigen aid distinction of basal cell, squamous cell and basosquamous carcinomas of the skin.
Beer TW; Shepherd P; Theaker JM
Histopathology; 2000 Sep; 37(3):218-23. PubMed ID: 10971697
[TBL] [Abstract][Full Text] [Related]
8. Basosquamous carcinoma and metatypical basal cell carcinoma: a review of treatment with Mohs micrographic surgery.
Allen KJ; Cappel MA; Killian JM; Brewer JD
Int J Dermatol; 2014 Nov; 53(11):1395-403. PubMed ID: 24961583
[TBL] [Abstract][Full Text] [Related]
9. Morpheaform Basal Cell Carcinomas With Areas of Predominantly Single-Cell Pattern of Infiltration: Diagnostic Utility of p63 and Cytokeratin.
East E; Fullen DR; Arps D; Patel RM; Palanisamy N; Carskadon S; Harms PW
Am J Dermatopathol; 2016 Oct; 38(10):744-50. PubMed ID: 27043336
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical study on keratin expression in certain cutaneous epithelial neoplasms. Basal cell carcinoma, pilomatricoma, and seborrheic keratosis.
Shimizu N; Ito M; Tazawa T; Sato Y
Am J Dermatopathol; 1989 Dec; 11(6):534-40. PubMed ID: 2481408
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical characterization of the differentiation state of basal cell carcinomas with special interest for infiltrating relapsing tumors.
Barbaud A; Simon M; Parache RM; Serre G
Eur J Dermatol; 1998; 8(5):320-4. PubMed ID: 9683887
[TBL] [Abstract][Full Text] [Related]
12. Basosquamous cell carcinoma: a survey of 76 patients and a comparative analysis of basal cell carcinomas and squamous cell carcinomas.
Betti R; Crosti C; Ghiozzi S; Cerri A; Moneghini L; Menni S
Eur J Dermatol; 2013; 23(1):83-6. PubMed ID: 23238332
[TBL] [Abstract][Full Text] [Related]
13. Decreased expression of thymidine phosphorylase/platelet-derived endothelial cell growth factor in basal cell carcinomas.
Stoebner PE; Le Gallic L; Berthe ML; Boulle N; Lallemant B; Marque M; Gaspard C; Delfour C; Lavabre-Bertrand T; Martinez J; Meunier L
Exp Dermatol; 2008 Nov; 17(11):908-15. PubMed ID: 18341568
[TBL] [Abstract][Full Text] [Related]
14. Clinical and epidemiological analysis of basosquamous carcinoma: results of the multicenter study.
Ciążyńska M; Sławińska M; Kamińska-Winciorek G; Lange D; Lewandowski B; Reich A; Pabianek M; Szczepaniak K; Hankiewicz A; Ułańska M; Morawiec J; Błasińska-Morawiec M; Morawiec Z; Piekarski J; Brodowski R; Zaryczańska A; Sobjanek M; Owczarek W; Słowińska M; Wróbel K; Bieniek A; Woźniacka A; Skibińska M; Narbutt J; Niemczyk W; Ciążyński K; Lesiak A
Sci Rep; 2020 Oct; 10(1):18475. PubMed ID: 33116191
[TBL] [Abstract][Full Text] [Related]
15. Expression of proliferating cell nuclear antigen in basal cell carcinomas and in squamous cell carcinomas of canine skin: correlation with mitotic index and histological features.
Maiolino P; Restucci B; De Vico G
Zentralbl Veterinarmed A; 1995 Jul; 42(5):339-43. PubMed ID: 8578908
[TBL] [Abstract][Full Text] [Related]
16. Signet ring cell basal cell carcinoma: a basal cell carcinoma with myoepithelial differentiation.
Kim YC; Vandersteen DP; Chung YJ; Myong NH
Am J Dermatopathol; 2001 Dec; 23(6):525-9. PubMed ID: 11801794
[TBL] [Abstract][Full Text] [Related]
17. Proliferating cell nuclear antigen (PCNA); prognostic value in the clinical recurrence of primary basal cell carcinoma.
Toth DP; Guenther LC; Shum DT
J Dermatol Sci; 1996 Jan; 11(1):36-40. PubMed ID: 8867765
[TBL] [Abstract][Full Text] [Related]
18. [Patterns of keratin protein expression in basal cell, metatypical and squamous cell carcinoma of human skin].
Karelina TV; Kazantseva IA
Arkh Patol; 1991; 53(4):29-32. PubMed ID: 1714712
[TBL] [Abstract][Full Text] [Related]
19. [Metatypical basal-cell carcinoma (MTC) or basosquamos carcinoma (BSC): surgical therapy].
Tarallo M; Cigna E; Fino P; Sorvillo V; Scuderi N
Ann Ital Chir; 2011; 82(5):389-94. PubMed ID: 21988047
[TBL] [Abstract][Full Text] [Related]
20. Expression of cytokeratin 8 in basal cell carcinoma: a comparative immunohistochemical and immunoelectron microscopy study.
Kooy AJ; Tank B; de Jong TA; Vuzevski VD; Bosman FT; van Joost T
Anticancer Res; 1996; 16(1):277-82. PubMed ID: 8615621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
